sb 203580 has been researched along with am 404 in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (am 404) | Trials (am 404) | Recent Studies (post-2010) (am 404) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 198 | 0 | 60 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumgrass, R; Frischbutter, S; Pätzel, M; Radbruch, A; Schultheis, K | 1 |
1 other study(ies) available for sb 203580 and am 404
Article | Year |
---|---|
Evaluation of calcineurin/NFAT inhibitor selectivity in primary human Th cells using bar-coding and phospho-flow cytometry.
Topics: Arachidonic Acids; Calcineurin Inhibitors; Drug Evaluation, Preclinical; Electronic Data Processing; Flow Cytometry; Fluorescence; Genes, Reporter; Humans; Imidazoles; Inhibitory Concentration 50; MAP Kinase Signaling System; NFATC Transcription Factors; Nitriles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Sulfones; T-Lymphocytes, Helper-Inducer; Transcription Factor RelA | 2012 |